Connect Biopharma Holdings Limited
CNTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76,194 | $64,979 | $47,778 | $269,206 |
| - Cash | $78,232 | $105,663 | $80,371 | $268,025 |
| + Debt | $178 | $465 | $438 | $125 |
| Enterprise Value | -$1,860 | -$40,219 | -$32,155 | $1,306 |
| Revenue | $26,033 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $26,033 | -$988 | -$1,031 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$21,792 | -$58,372 | -$117,030 | -$201,718 |
| % Margin | -83.7% | – | – | – |
| Net Income | -$15,628 | -$59,503 | -$116,415 | -$205,205 |
| % Margin | -60% | – | – | – |
| EPS Diluted | -0.28 | -1.08 | -14.5 | -25 |
| % Growth | 74.1% | 92.6% | 42% | – |
| Operating Cash Flow | -$23,612 | -$47,930 | -$99,270 | -$85,568 |
| Capital Expenditures | -$750 | -$294 | -$4,282 | -$7,463 |
| Free Cash Flow | -$24,362 | -$48,224 | -$103,552 | -$93,031 |